| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDGL | Common Stock | Award | $0 | +5.79K | +38.57% | $0.00 | 20.8K | Jan 23, 2024 | Direct | F1, F2 |
| holding | MDGL | Common Stock | 438K | Jan 23, 2024 | Direct | ||||||
| holding | MDGL | Common Stock | 656K | Jan 23, 2024 | By SQN, LLC | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDGL | Stock Option (Right to Buy) | Award | $0 | +8.72K | $0.00 | 8.72K | Jan 23, 2024 | Common Stock | 8.72K | $229.00 | Direct | F4 | |
| transaction | MDGL | Market Stock Unit | Award | $0 | +5.79K | $0.00 | 5.79K | Jan 23, 2024 | Common Stock | 5.79K | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Represents a grant of restricted stock units, which vest as to 25% of the shares on each of January 23, 2025, January 23, 2026, January 23, 2027 and January 23, 2028, provided the Reporting Person continues in service with the Issuer on each such date. |
| F2 | Represents restricted stock units granted to the Reporting Person on January 16, 2023 and January 23, 2024. |
| F3 | The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| F4 | The option vests as to 25% of the shares on the first anniversary of the date of grant (January 23, 2025) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. |
| F5 | Each market stock unit, which is performance-based, represents the contingent right to receive one share of common stock. The amount reported represents the target number of shares which may be issued upon vesting. The market stock units will vest upon certification concerning the Company's stock price performance measured against biotechnology stock index companies for the entire performance period ending December 31, 2026. |
**As attorney-in-fact for Reporting Person